ABSTRACT
Objective:To explore the differences on clinical characteristics, concomitant diseases and treatment status between psoriasis and psoriatic arthritis (PsA), and provide clues for the early diagnosis and treatment of PsA.Methods:Data were collected by in-person interview of 225 patients with psoriasis and 299 patients with PSA who visited the department of rheumatology and Immunology and Department of Dermatology in People′s Hospital of Peking University from November 2020 to May 2021. After informed consent, the questionnaire was completed on site. The differences of clinical characteristics, concomitant diseases, mental health evaluation and treatment status between patients with arthritis (PsA) and patients with psoriasiswere analyzed and compared. Enumeration data were described by frequency. Chi square test was used to compare categorical variables. Multivariate Logistic regression analysis was used to determine the independent risk factors. P value of less than 0.05 was considered statistically significant. Results:Dactylitis [ OR(95% CI)=8.439(4.677,15.226), P<0.001], hip pain [ OR(95% CI)=3.442(1.829,6.480), P<0.001], heel pain [ OR(95% CI)=2.621(1.652,4.157), P<0.001] and low back pain [ OR(95% CI)=1.924(1.156,3.203), P=0.012] may be closely related to the progression of PsA ( P<0.05). The three most common concomitant diseases of patients with PsA and psoriasis both were overweight [43.1%(129/299)、29.3%(66/225)], fatty liver [(28.4%(85/299)、23.1%(52/225)]and hypertension[24.1%(72/299、13.3%(30/225)]. The proportion of osteoporosis in PsA group at the age of 30-39 and 40-49 years old was significantly higher than those in psoriasis group (30-39 years old:12.5%(10/80) vs 1.5%(1/65), χ2=6.14, P=0.013; 40~49 years old: 19.2%(15/78) vs 2.0%(1/51), χ2=8.46, P=0.004]. The proportion of hypertension in PsA group was also higher than that in psoriasis group at the age of 40~49 years old[7.0% (21/78) vs 2.7%(6/51), χ2=4.99, P=0.026)]. And the proportion of fatty liver in PsA group was also higher than that in psoriasis group at the age ≥60 years old [(46.0%(23/50) vs 29.1(7/24), χ2=4.99, P=0.025)]. Among 299 PsA patients, 47.1%(141/299) had anxiety tendency, 45.2%(135/299) had sleep disorder and 41.8%(125/299) had depression tendency. Among 225 psoriasis patients, 44.4%(100/225) had anxiety tendency, 40%(90/225) had sleep disorder and 36.9%(83/225) had depression tendency, there was no significant difference in above-mentioned situations between the PsA and psoriasis patients ( P>0.05). Conclusion:More attention should be paid to the management of concomitant diseases and psychological intervention in patients with PsA. When psoriasis patients occur with heel pain, dactylitis, low back pain and hip pain, the risk of development into PsA should be considered.
ABSTRACT
Metabolic-dysfunction associated fatty liver disease (MAFLD) is a common concomitant disease of breast cancer. It is one of the main causes of liver damage during chemotherapy and also an important cause of liver damage during endocrine therapy or follow-up, which seriously affects the quality of life and prognosis of breast cancer patients. Nonalcoholic fatty liver disease was renamed as MAFLD, which changed the original "exclusive diagnosis" to "inclusive diagnosis" and the non-negligible role of metabolic factors in the occurrence and development of fatty liver disease was recognized, but the clinical attention is not enough at present. More attention should be paid to the diagnosis and treatment of MAFLD in breast cancer patients because the proportion and risk of metabolic disorders are higher than that in general people. In this article, we will focus on the clinical significance, prevention and treatment of the new definition of MAFLD in the comprehensive management of concomitant diseases of breast cancer, so as to further improve the quality of life and prognosis of breast cancer patients.
ABSTRACT
Breast cancer is considered as a chronic disease, hence breast cancer these patients require extensive and effective chronic disease management. With the development of the "Healthy China 2030" program and the "Comprehensive Management Guideline for Breast Cancer Follow-up and Concomitant Diseases, "more attention is being paid to the management of concomitant diseases of breast cancer (CDBC). This involves improving multidisciplinary treatment by collaborating with oncologists and related specialists to develop psycho-oncology, oncocardiology, and other oncology subdisciplines. Consultation-liaison psychiatry has been successfully used in the treatment of patients with cancer. Therefore, for the prevention and treatment of CDBC, it is important to establish and im-prove rehabilitation medicine and other units, such as cardiovascular, endocrinology, and gynecology units. This, in turn, could help im-prove the patient's quality of life and prognosis.
ABSTRACT
In recent years, with the emphasis on breast cancer screening and the improvement of breast cancer diagnosis and treatment, five-year survival rate and the overall survival time of breast cancer patients have been significantly improved in China. The adverse events caused by patients′ age, changes in hormone levels or anti-cancer treatment during follow-up have become new challenges in the management of patients with breast cancer, not only affecting the quality of life, but also impacting disease recurrence and death. The management of patients should not be restricted to the diagnosis and treatment of breast cancer, but to a most comprehensive management. This could improve the therapeutic efficacy of anti-cancer treatment and the quality of life of patients. Based on the current landscape of treatment and follow-up of breast cancer patients in China, the experts committee drafted the "Comprehensive Management Guideline for Breast Cancer Follow-up and Concomitant Diseases" according to the literature and relevant guidelines. This guideline is composed of four parts: path diagram, follow-up management, concomitant diseases and adverse events management. It aims to standardize the long-term follow-up of breast cancer patients, guide clinicians to deal with the concomitant diseases and adverse events, and further improve the prognosis and quality of life of breast cancer patients in China.
ABSTRACT
Primary sclerosing cholangitis (PSC) is a common autoimmune liver disease,and the diversity of its treatment methods has been hotly discussed by scholars in various countries.As the best treatment,end-stage liver transplantation (LT),due to the related diseases,such as postoperative complications greatly limits its wide application in clinical practice.Early assessment and intervention can reduce the risk of concomitant disease and reduce the occurrence of postoperative complications.In this paper,the status of LT indications,timing and related disease management,postoperative complications and other aspects of PSC patients were reviewed.
ABSTRACT
The outline of "Healthy China 2030 Program" has put forward a "double-aspect" health management policy of " all-around and all-cycle protection of peoples' health".Therefore,Chinese experts started to draw up the "comprehensive management guidelines of following-up and concomitant diseases of breast cancer patients" which begins to focus on the concomitant diseases of breast cancer caused by the untoward effects of acute therapy and chronic treatment,and aims at providing integrated health care strategy in the convalescence period for clinicians and breast cancer patients.This is the first time to standardize the principles of preventing and managing concomitant diseases of breast cancer during cancer therapy and follow-ups.Currently,three kinds of disease entities regarding bone,cardiovascular and dyslipidemia,mental and psychiatric disorders were defined as concomitant diseases of breast cancer.Besides,authors have found higher prevalence of sleep disorder,cognitive dysfunction,diabetes and prediabetes,thyroid diseases and metabolic syndrome,in which these diseases should also be considered as concomitant diseases of breast cancer.We'll discuss these diseases in this paper to increase the consciousness in prevention and management of them,and improve the life quality and prognosis of breast cancer patients.
ABSTRACT
INTRODUÇÃO: Considerada doença negligenciada pela OMS, a Leishmaniose visceral (LV) tem se expandido e urbanizado, sendo sua transmissão e expansão associadas a diversos fatores. OBJETIVO: Avaliar aspectos epidemiológicos da LV no município de Aracaju/SE, por meio de estudo retrospectivo da série histórica de LV humana e canina no período de 1999-2008. MÉTODOS: Foram utilizados dados secundários do SINAN para os casos humanos, e o resultado dos inquéritos caninos e atendimentos da demanda passiva do Centro de Controle de Zoonoses (CCZ). RESULTADOS: Foram notificados 192 casos autóctones de LV humana, sendo 63,5% do gênero masculino. Crianças entre 1 e 4 anos foram mais acometidas (29,2%), seguidas de adultos entre 20-29 anos (15,6%) e de crianças entre 5-9 anos (15,1%). A letalidade geral foi de 8,9%, sendo mais acentuada em pessoas entre 60 a 69 anos (60%); 32,3% dos casos autóctones realizaram sorologia para HIV, com positividade de 6,9%. A confirmação laboratorial foi realizada principalmente mediante a imunofluorescência indireta isolada (71,1%). Dos 58.161 cães que realizaram sorologia a positividade foi de 5,4%, sendo 87,0% dos inquéritos realizados anualmente pelo CCZ, com uma positividade de 4,4%. Dos 7.501 cães trazidos ao CCZ por diversas queixas, o exame sorológico foi reagente em 12,0%. CONCLUSÃO: Os dados denotam o caráter endêmico da LV no município, mostrando a necessidade de ações que permitam a diminuição do risco para a população, principalmente aquela onde a incidência e a letalidade são maiores, como melhorias no diagnóstico da LV, assim como na co-infecção com HIV e no monitoramento da população canina, entre outros.
INTRODUCTION: Considered as a neglected disease by the WHO, visceral leishmaniasis (VL) has expanded and urbanized. Its transmission and expansion have been linked to several factors. OBJECTIVE: To evaluate the epidemiological aspects of VL in the city of Aracaju/SE, through retrospective studies of the historical series of human and canine VL in the 1999-2008 period. METHODS: Secondary data from SINAN (Information System for Reportable Diseases) for human cases were used. Data from canine surveys and from the Zoonosis Control Center´s (ZCC) passive demand were used for canine cases. RESULTS: 192 autochthonous cases of human VL were reported, and 63.5% were male. Children aged 1-4 years were the most affected (29.2%), followed by adults aged 20-29 years (15.6%) and children aged 5-9 years (15.1%). General mortality was 8.9%, and it was higher for the 60-69 year age group (60%); 32.3% of autochthonous cases performed serology for HIV, with a 6.9% positivity. Laboratory results were confirmed mostly by indirect isolated immunofluorescence (71.1%). 58,161 dogs were serologically tested for VL, with a positivity rate of 5.4%, while 87.0% of the surveys conducted annually by the ZCC, have a 4.4%positivity rate for VL. Of the 7,501 dogs that were brought to the ZCC for multiple complaints, the serological test was positive in 12.0%. CONCLUSION: Data show the endemicity of VL in the city, revealing the need for actions to reduce the risk of the population, mostly for the group with higher incidence and mortality, such as improvement in the diagnosis of VL and its HIV-associated infection, along with monitoring of the dog population, among others.